At Glycome BioPharma, we are building a diversified portfolio of collaborators and smart investors.
We welcome partnerships that complement our glycan technology, discovery and development strategies.
Our laboratories are based out of Trinity Biomedical Sciences Institute, Ireland’s largest biomedical research centre and a hub for Advanced Materials and BioEngineering Research. This highly praised educational and research facility is home to a number of schools including Medicine, Pharmaceutical Science, Engineering, Chemistry, Biochemistry and Immunology which concentrates world class expertise in addressing major challenges in facing biomedical devices, pharmacology and clinical medicine.
Enterprise Ireland has acclaimed Glycome BioPharma as a High Potential Start-Up that is led by an experienced management team and has the capacity to build scale through R&D, technology and IP development. Working together with our partners, Enterprise Ireland will continue to support and cultivate the reach of our innovative products to international markets.